1255055002: Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Selective adhesion molecule inhibitor-containing product\Alpha-4 integrin receptor antagonist-containing product\Vedolizumab-containing product\Vedolizumab-containing product in parenteral dose form\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial\Vedolizumab 300 mg powder for solution for infusion vial
• \Medicinal product categorised by disposition\Selective adhesion molecule inhibitor-containing product\Alpha-4 integrin receptor antagonist-containing product\Vedolizumab-containing product\Vedolizumab only product\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial\Vedolizumab 300 mg powder for solution for infusion vial
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Vedolizumab-containing product\Vedolizumab-containing product in parenteral dose form\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial\Vedolizumab 300 mg powder for solution for infusion vial
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Vedolizumab-containing product\Vedolizumab only product\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial\Vedolizumab 300 mg powder for solution for infusion vial
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Antibody-containing product\Monoclonal antibody-containing product\Vedolizumab-containing product\...
• \Vedolizumab-containing product in parenteral dose form\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial\Vedolizumab 300 mg powder for solution for infusion vial
• \Vedolizumab only product\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial\Vedolizumab 300 mg powder for solution for infusion vial
• \Product manufactured as parenteral dose form\Vedolizumab-containing product in parenteral dose form\Vedolizumab only product in parenteral dose form\Vedolizumab 300 mg powder for solution for infusion and/or injection vial\Vedolizumab 300 mg powder for solution for infusion vial

Status: current, Defined. Date: 31-Oct 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5144259015	Vedolizumab 300 mg powder for solution for infusion vial	en	Synonym	Active	Case insensitive	SNOMED CT core
5144260013	Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core

Expanded Value Set

Reference Sets

Australian dialect reference set

Back to Start